APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs Based on TGF-β1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drugs Based on TGF-β1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026176 pages

Choose your research edition.

Industry ResearchDrugs Based on TGF-β1 Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs Based on TGF-β1 Industry Growth and Trends Forecast to 203262 pages · $3,450 USDMarket StructureGlobal Drugs Based on TGF-β1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs Based on TGF-β1 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs Based on TGF-β1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Drugs Based on TGF-β1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drugs Based on TGF-β1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs Based on TGF-β1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs Based on TGF-β1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drugs Based on TGF-β1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs Based on TGF-β1 include Roche and Shionogi Ltd among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drugs Based on TGF-β1 market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs Based on TGF-β1 and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs Based on TGF-β1 revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drugs Based on TGF-β1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs Based on TGF-β1 Segment by Company

Roche

Shionogi Ltd

Drugs Based on TGF-β1 Segment by Type

Pirfenidone

Galunisertib

Others

Drugs Based on TGF-β1 Segment by Application

IPF

Cancer

Others

Drugs Based on TGF-β1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs Based on TGF-β1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs Based on TGF-β1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs Based on TGF-β1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs Based on TGF-β1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs Based on TGF-β1 industry.

Chapter 3: Detailed analysis of Drugs Based on TGF-β1 companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs Based on TGF-β1revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drugs Based on TGF-β1 Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Pirfenidone Table 3. Key Players of Galunisertib Table 4. Key Players of Others Table 4. Global Drugs Based on TGF-β1 Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of IPF Table 6. Key Players of Cancer Table 7. Key Players of Others Table 8. Global Drugs Based on TGF-β1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Drugs Based on TGF-β1 Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Drugs Based on TGF-β1 Market Share by Region (2021-2026) Table 11. Global Drugs Based on TGF-β1 Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Drugs Based on TGF-β1 Market Share by Region (2027-2032) Table 13. Drugs Based on TGF-β1 Industry Trends Table 14. Drugs Based on TGF-β1 Industry Drivers Table 15. Drugs Based on TGF-β1 Industry Opportunities and Challenges Table 16. Drugs Based on TGF-β1 Industry Restraints Table 17. Global Drugs Based on TGF-β1 Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Drugs Based on TGF-β1 Revenue Market Share by Company (2021-2026) Table 19. Global Drugs Based on TGF-β1 Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Drugs Based on TGF-β1 Key Company Head Office and Area Served Table 21. Global Drugs Based on TGF-β1 Company, Product Type & Application Table 22. Global Drugs Based on TGF-β1 Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Drugs Based on TGF-β1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Drugs Based on TGF-β1 Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drugs Based on TGF-β1 Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Drugs Based on TGF-β1 Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Drugs Based on TGF-β1 Revenue Market Share by Type (2021-2026) Table 29. Global Drugs Based on TGF-β1 Revenue Market Share by Type (2027-2032) Table 30. Global Drugs Based on TGF-β1 Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drugs Based on TGF-β1 Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Drugs Based on TGF-β1 Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Drugs Based on TGF-β1 Revenue Market Share by Application (2021-2026) Table 34. Global Drugs Based on TGF-β1 Revenue Market Share by Application (2027-2032) Table 35. Roche Company Information Table 36. Roche Business Overview Table 37. Roche Drugs Based on TGF-β1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Roche Drugs Based on TGF-β1 Product Portfolio Table 39. Roche Recent Development Table 40. Shionogi Ltd Company Information Table 41. Shionogi Ltd Business Overview Table 42. Shionogi Ltd Drugs Based on TGF-β1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Shionogi Ltd Drugs Based on TGF-β1 Product Portfolio Table 44. Shionogi Ltd Recent Development Table 45. North America Drugs Based on TGF-β1 Market Size by Type (2021-2026) & (US$ Million) Table 46. North America Drugs Based on TGF-β1 Market Size by Type (2027-2032) & (US$ Million) Table 47. North America Drugs Based on TGF-β1 Market Size by Application (2021-2026) & (US$ Million) Table 48. North America Drugs Based on TGF-β1 Market Size by Application (2027-2032) & (US$ Million) Table 49. North America Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 50. North America Drugs Based on TGF-β1 Market Size by Country (2021-2026) Table 51. North America Drugs Based on TGF-β1 Market Size by Country (2027-2032) Table 52. Europe Drugs Based on TGF-β1 Market Size by Type (2021-2026) & (US$ Million) Table 53. Europe Drugs Based on TGF-β1 Market Size by Type (2027-2032) & (US$ Million) Table 54. Europe Drugs Based on TGF-β1 Market Size by Application (2021-2026) & (US$ Million) Table 55. Europe Drugs Based on TGF-β1 Market Size by Application (2027-2032) & (US$ Million) Table 56. Europe Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Europe Drugs Based on TGF-β1 Market Size by Country (2021-2026) Table 58. Europe Drugs Based on TGF-β1 Market Size by Country (2027-2032) Table 59. China Drugs Based on TGF-β1 Market Size by Type (2021-2026) & (US$ Million) Table 60. China Drugs Based on TGF-β1 Market Size by Type (2027-2032) & (US$ Million) Table 61. China Drugs Based on TGF-β1 Market Size by Application (2021-2026) & (US$ Million) Table 62. China Drugs Based on TGF-β1 Market Size by Application (2027-2032) & (US$ Million) Table 63. Asia Drugs Based on TGF-β1 Market Size by Type (2021-2026) & (US$ Million) Table 64. Asia Drugs Based on TGF-β1 Market Size by Type (2027-2032) & (US$ Million) Table 65. Asia Drugs Based on TGF-β1 Market Size by Application (2021-2026) & (US$ Million) Table 66. Asia Drugs Based on TGF-β1 Market Size by Application (2027-2032) & (US$ Million) Table 67. Asia Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 68. Asia Drugs Based on TGF-β1 Market Size by Country (2021-2026) Table 69. Asia Drugs Based on TGF-β1 Market Size by Country (2027-2032) Table 70. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Type (2021-2026) & (US$ Million) Table 71. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Type (2027-2032) & (US$ Million) Table 72. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Application (2021-2026) & (US$ Million) Table 73. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Application (2027-2032) & (US$ Million) Table 74. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2021-2026) Table 76. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2027-2032) Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Drugs Based on TGF-β1 Product Image Figure 2. Global Drugs Based on TGF-β1 Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drugs Based on TGF-β1 Market Share by Type: 2025 VS 2032 Figure 4. Pirfenidone Image Figure 5. Galunisertib Image Figure 6. Others Image Figure 7. Global Drugs Based on TGF-β1 Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Drugs Based on TGF-β1 Market Share by Application: 2025 VS 2032 Figure 9. IPF Image Figure 10. Cancer Image Figure 11. Others Image Figure 12. Global Drugs Based on TGF-β1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 14. Global Drugs Based on TGF-β1 Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Drugs Based on TGF-β1 Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Drugs Based on TGF-β1 Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Drugs Based on TGF-β1 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drugs Based on TGF-β1 Revenue Market Share by Type (2021-2032) Figure 21. Global Drugs Based on TGF-β1 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drugs Based on TGF-β1 Revenue Market Share by Application (2021-2032) Figure 23. North America Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 24. North America Drugs Based on TGF-β1 Market Share by Type (2021-2032) Figure 25. North America Drugs Based on TGF-β1 Market Share by Application (2021-2032) Figure 26. North America Drugs Based on TGF-β1 Market Share by Country (2021-2032) Figure 27. United States Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 28. Canada Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 30. Europe Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 31. Europe Drugs Based on TGF-β1 Market Share by Type (2021-2032) Figure 32. Europe Drugs Based on TGF-β1 Market Share by Application (2021-2032) Figure 33. Europe Drugs Based on TGF-β1 Market Share by Country (2021-2032) Figure 34. Germany Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 35. France Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 37. Italy Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 38. Russia Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 40. China Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 41. China Drugs Based on TGF-β1 Market Share by Type (2021-2032) Figure 42. China Drugs Based on TGF-β1 Market Share by Application (2021-2032) Figure 43. Asia Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 44. Asia Drugs Based on TGF-β1 Market Share by Type (2021-2032) Figure 45. Asia Drugs Based on TGF-β1 Market Share by Application (2021-2032) Figure 46. Asia Drugs Based on TGF-β1 Market Share by Country (2021-2032) Figure 47. Japan Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 51. India Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 52. Australia Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Drugs Based on TGF-β1 Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Drugs Based on TGF-β1 Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Drugs Based on TGF-β1 Market Share by Country (2021-2032) Figure 57. Brazil Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 62. UAE Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 64. Chile Drugs Based on TGF-β1 Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Pirfenidone
  • Galunisertib
  • Others
Applications
  • IPF
  • Cancer
  • Others
Companies covered
  • Roche
  • Shionogi Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drugs Based on TGF-β1 Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Pirfenidone
  5. 1.2.3 Galunisertib
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Drugs Based on TGF-β1 Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 IPF
  10. 1.3.3 Cancer
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Drugs Based on TGF-β1 Growth Trends by Region
  14. 1.5.1 Global Drugs Based on TGF-β1 Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Drugs Based on TGF-β1 Market Size by Region (2021-2026)
  16. 1.5.3 Drugs Based on TGF-β1 Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Drugs Based on TGF-β1 Market Dynamics
  1. 2.1 Drugs Based on TGF-β1 Industry Trends
  2. 2.2 Drugs Based on TGF-β1 Industry Drivers
  3. 2.3 Drugs Based on TGF-β1 Industry Opportunities and Challenges
  4. 2.4 Drugs Based on TGF-β1 Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drugs Based on TGF-β1 Revenue by Company (2021-2026)
  2. 3.2 Global Drugs Based on TGF-β1 Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drugs Based on TGF-β1 Key Company Head office and Area Served
  4. 3.4 Global Drugs Based on TGF-β1 Company, Product Type & Application
  5. 3.5 Global Drugs Based on TGF-β1 Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drugs Based on TGF-β1 Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drugs Based on TGF-β1 Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drugs Based on TGF-β1 Tier 1, Tier 2, and Tier 3
4 Drugs Based on TGF-β1 Market by Type
  1. 4.1 Global Drugs Based on TGF-β1 Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drugs Based on TGF-β1 Market Size by Type (2021-2032)
  3. 4.3 Global Drugs Based on TGF-β1 Market Size Share by Type (2021-2032)
5 Drugs Based on TGF-β1 Market by Application
  1. 5.1 Global Drugs Based on TGF-β1 Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drugs Based on TGF-β1 Market Size by Application (2021-2032)
  3. 5.3 Global Drugs Based on TGF-β1 Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Drugs Based on TGF-β1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche Drugs Based on TGF-β1 Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Shionogi Ltd
  8. 6.2.1 Shionogi Ltd Company Information
  9. 6.2.2 Shionogi Ltd Business Overview
  10. 6.2.3 Shionogi Ltd Drugs Based on TGF-β1 Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Shionogi Ltd Drugs Based on TGF-β1 Product Portfolio
  12. 6.2.5 Shionogi Ltd Recent Developments
7 North America
  1. 7.1 North America Drugs Based on TGF-β1 Market Size (2021-2032)
  2. 7.2 North America Drugs Based on TGF-β1 Market Size by Type
  3. 7.2.1 North America Drugs Based on TGF-β1 Market Size by Type (2021-2026)
  4. 7.2.2 North America Drugs Based on TGF-β1 Market Size by Type (2027-2032)
  5. 7.2.3 North America Drugs Based on TGF-β1 Market Share by Type (2021-2032)
  6. 7.3 North America Drugs Based on TGF-β1 Market Size by Application
  7. 7.3.1 North America Drugs Based on TGF-β1 Market Size by Application (2021-2026)
  8. 7.3.2 North America Drugs Based on TGF-β1 Market Size by Application (2027-2032)
  9. 7.3.3 North America Drugs Based on TGF-β1 Market Share by Application (2021-2032)
  10. 7.4 North America Drugs Based on TGF-β1 Market Size by Country
  11. 7.4.1 North America Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drugs Based on TGF-β1 Market Size by Country (2021-2026)
  13. 7.4.3 North America Drugs Based on TGF-β1 Market Size by Country (2027-2032)
  14. 7.4.4 North America Drugs Based on TGF-β1 Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drugs Based on TGF-β1 Market Size (2021-2032)
  2. 8.2 Europe Drugs Based on TGF-β1 Market Size by Type
  3. 8.2.1 Europe Drugs Based on TGF-β1 Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drugs Based on TGF-β1 Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drugs Based on TGF-β1 Market Share by Type (2021-2032)
  6. 8.3 Europe Drugs Based on TGF-β1 Market Size by Application
  7. 8.3.1 Europe Drugs Based on TGF-β1 Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drugs Based on TGF-β1 Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drugs Based on TGF-β1 Market Share by Application (2021-2032)
  10. 8.4 Europe Drugs Based on TGF-β1 Market Size by Country
  11. 8.4.1 Europe Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drugs Based on TGF-β1 Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drugs Based on TGF-β1 Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drugs Based on TGF-β1 Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drugs Based on TGF-β1 Market Size (2021-2032)
  2. 9.2 China Drugs Based on TGF-β1 Market Size by Type
  3. 9.2.1 China Drugs Based on TGF-β1 Market Size by Type (2021-2026)
  4. 9.2.2 China Drugs Based on TGF-β1 Market Size by Type (2027-2032)
  5. 9.2.3 China Drugs Based on TGF-β1 Market Share by Type (2021-2032)
  6. 9.3 China Drugs Based on TGF-β1 Market Size by Application
  7. 9.3.1 China Drugs Based on TGF-β1 Market Size by Application (2021-2026)
  8. 9.3.2 China Drugs Based on TGF-β1 Market Size by Application (2027-2032)
  9. 9.3.3 China Drugs Based on TGF-β1 Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drugs Based on TGF-β1 Market Size (2021-2032)
  2. 10.2 Asia Drugs Based on TGF-β1 Market Size by Type
  3. 10.2.1 Asia Drugs Based on TGF-β1 Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drugs Based on TGF-β1 Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drugs Based on TGF-β1 Market Share by Type (2021-2032)
  6. 10.3 Asia Drugs Based on TGF-β1 Market Size by Application
  7. 10.3.1 Asia Drugs Based on TGF-β1 Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drugs Based on TGF-β1 Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drugs Based on TGF-β1 Market Share by Application (2021-2032)
  10. 10.4 Asia Drugs Based on TGF-β1 Market Size by Country
  11. 10.4.1 Asia Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drugs Based on TGF-β1 Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drugs Based on TGF-β1 Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drugs Based on TGF-β1 Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drugs Based on TGF-β1 Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drugs Based on TGF-β1 Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drugs Based on TGF-β1 Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drugs Based on TGF-β1 Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst